Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

'Snowzilla' Delays Drug Price Hearing; Shkreli Travel OK'd

This article was originally published in Scrip

Executive Summary

A federal judge has given his OK for Martin Shkreli – the former Turing Pharmaceuticals Inc. CEO Americans love to hate and who has become despised among the big players in the biopharmaceutical industry – to travel to Washington to comply with a subpoena issued by lawmakers summoning him to a hearing on drug prices.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064304

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel